Alendronate News
Merrion: osteoporosis drug has novel benefits
Merrion has announced positive phase II results for its osteoporosis drug MER-103.
Ontario government invests in bone health
FOSAVANCE(R) (ALENDRONATE SODIUM 70 MG/CHOLECALCIFEROL 2800 IU (VITAMIN D(3))), the first and only therapy to combine FOSAMAX(R), the world's leading osteoporosis treatment, and vitamin D, an important component in treating...
JAMA's Fosamax study funded by Merck
Let no one say the studies in JAMA are funded by hidden drug company money. The funding is right out in the open.
Stopping alendronate may be OK for postmenopausal women
Most postmenopausal women who took the osteoporosis drug alendronate for 5 years and then stopped did not have an increased risk for nonvertebral fractures in the next 5 years, suggesting the medication has a lasting effect,...
Study of Over 33,000 Women Comparing Two Most Prescribed Osteoporosis Treatments Shows Significant Difference in Hip Fracture Reduction
Data published today from a retrospective study of over 33,000postmenopausal women showed that among patients newly prescribed one of thetwo most popular osteoporosis treatments, patients taking Actonel(R)(risedronate sodium)...